SS
TNXP icon

Simplicity Solutions’s Tonix Pharmaceuticals TNXP Stock Holding History

Simplicity Solutions’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2
Closed -$21.7K – 1221
2023
Q1 		$21.7K Buy
+2
New +$34.3K ﹤0.01% 1132

Other funds holding TNXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Simplicity Solutions's TNXP Position: Q2 2023 in Review

Simplicity Solutions sold out of Tonix Pharmaceuticals (TNXP) in Q2 2023, closing a stake of 2 shares — an estimated $21.7K sold.

Simplicity Solutions first reported a position in TNXP in Q1 2023 and held it in 1 quarter. The position peaked at $21.7K in Q1 2023. 14 funds tracked by Wall St. Rank hold TNXP as of Q2 2023.

  • Simplicity Solutions reported no remaining Tonix Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Simplicity Solutions sold 2 Tonix Pharmaceuticals shares in Q2 2023, an estimated $21.7K.
  • Simplicity Solutions first reported a position in Tonix Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Simplicity Solutions's Tonix Pharmaceuticals position peaked at $21.7K in Q1 2023.
  • 14 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2023.

Based on Simplicity Solutions's 13F filing for Q2 2023, filed 26 Jul 2023.